Olin Corporation (USD) Olin Corporation is a global producer and supplier of chemical products, serving markets across the United States, Europe, and internationally. The company's operations are divided into three distinct business segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment provides a comprehensive range of fundamental industrial chemicals. These include chlorine and caustic soda, key vinyl compounds such as ethylene dichloride and vinyl chloride monomers, and various chlorinated organic compounds like methyl chloride, methylene chloride, chloroform, carbon tetrachloride, and perchloroethylene. This division also supplies essential substances including hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and sodium hypochlorite, alongside chlorinated organic intermediates and solvents, which underpin numerous industrial processes. The Epoxy segment specializes in epoxy materials and their foundational precursors. This encompasses aromatics like acetone, bisphenol, cumene, and phenol, in addition to allyl chloride, epichlorohydrin, and glycerin, which are critical for manufacturers producing polymers, resins, plastics, and for water purification applications. The segment further offers liquid and solid epoxy resins, integral to products such as adhesives, marine applications, protective coatings, composites, and flooring. Moreover, it supplies converted epoxy resins and additives that find utility in electrical laminates, paints, coatings, wind turbine blades, electronics, and diverse construction projects. The Winchester segment is responsible for a broad portfolio of ammunition products. Its offerings span from sporting ammunition—including shotshells, small-caliber centerfire, and rimfire ammunition for hunters, recreational shooters, and law enforcement agencies—to small-caliber military ammunition designed for infantry and mounted weaponry. Additionally, this segment produces industrial products like gauge loads and powder-actuated tool loads, vital for maintenance in the power and concrete industries, as well as for powder-actuated tools in construction. Olin markets its products through its dedicated sales force, directly to industrial clients, mass merchants, retailers, wholesalers, and other distributors. The company also serves the U.S. Government and its primary contractors. Founded in 1892, Olin Corporation's corporate headquarters are located in Clayton, Missouri.

Olin Corporation (USD) Active

190 Carondelet Plaza, Clayton, MO, US, 63105

Stock Price USD

Price Change

Last Dividend USD

C+

Latest Rating

OLN's stock peer is AVTR (Avantor, Inc.)

OLN's stock peer is AXTA (Axalta Coating Systems Ltd.)

OLN's stock peer is DD (DuPont de Nemours, Inc.)

OLN's stock peer is EMN (Eastman Chemical Company)

OLN's stock peer is ESI (Element Solutions Inc)

OLN's stock peer is FUL (H.B. Fuller Company)

OLN's stock peer is KRO (Kronos Worldwide, Inc.)

OLN's stock peer is KWR (Quaker Chemical Corporation)

OLN's stock peer is MTX (Minerals Technologies Inc.)

OLN's stock peer is RPM (RPM International Inc.)

OLN's stock peer is SXT (Sensient Technologies Corporation)

OLN's stock peer is WLK (Westlake Corporation)

OLN's stock peer is WTTR (Select Water Solutions, Inc.)

Basic Materials Chemicals - Specialty

Olin Corporation is a global producer and supplier of chemical products, serving markets across the United States, Europe, and internationally. The company's operations are divided into three distinct business segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment provides a comprehensive range of fundamental industrial chemicals. These include chlorine and caustic soda, key vinyl compounds such as ethylene dichloride and vinyl chloride monomers, and various chlorinated organic compounds like methyl chloride, methylene chloride, chloroform, carbon tetrachloride, and perchloroethylene. This division also supplies essential substances including hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and sodium hypochlorite, alongside chlorinated organic intermediates and solvents, which underpin numerous industrial processes. The Epoxy segment specializes in epoxy materials and their foundational precursors. This encompasses aromatics like acetone, bisphenol, cumene, and phenol, in addition to allyl chloride, epichlorohydrin, and glycerin, which are critical for manufacturers producing polymers, resins, plastics, and for water purification applications. The segment further offers liquid and solid epoxy resins, integral to products such as adhesives, marine applications, protective coatings, composites, and flooring. Moreover, it supplies converted epoxy resins and additives that find utility in electrical laminates, paints, coatings, wind turbine blades, electronics, and diverse construction projects. The Winchester segment is responsible for a broad portfolio of ammunition products. Its offerings span from sporting ammunition—including shotshells, small-caliber centerfire, and rimfire ammunition for hunters, recreational shooters, and law enforcement agencies—to small-caliber military ammunition designed for infantry and mounted weaponry. Additionally, this segment produces industrial products like gauge loads and powder-actuated tool loads, vital for maintenance in the power and concrete industries, as well as for powder-actuated tools in construction. Olin markets its products through its dedicated sales force, directly to industrial clients, mass merchants, retailers, wholesalers, and other distributors. The company also serves the U.S. Government and its primary contractors. Founded in 1892, Olin Corporation's corporate headquarters are located in Clayton, Missouri.

100%

Dcf Rating

20%

Return On Equity

20%

Return On Assets

20%

Debt To Equity

20%

Price To Earnings

60%

Price To Book

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
2026-05-14	2026-06-12	0.20	2.88 %	Quarterly
2026-03-03	2026-03-13	0.20	3.29 %	Quarterly
2025-11-28	2025-12-12	0.20	3.79 %	Quarterly
2025-08-28	2025-09-12	0.20	3.50 %	Quarterly
2025-05-15	2025-06-13	0.20	3.79 %	Quarterly
2025-03-06	2025-03-14	0.20	3.22 %	Quarterly
2024-11-14	2024-12-13	0.20	1.91 %	Quarterly
2024-08-08	2024-09-13	0.20	1.95 %	Quarterly
2024-05-09	2024-06-14	0.20	1.44 %	Quarterly
2024-03-07	2024-03-15	0.20	1.44 %	Quarterly
2023-11-09	2023-12-08	0.20	1.86 %	Quarterly
2023-08-10	2023-09-08	0.20	1.37 %	Quarterly
2023-05-11	2023-06-09	0.20	1.49 %	Quarterly
2023-03-06	2023-03-13	0.20	1.33 %	Quarterly
2022-11-10	2022-12-09	0.20	1.45 %	Quarterly
2022-08-10	2022-09-09	0.20	1.49 %	Quarterly
2022-05-10	2022-06-10	0.20	1.32 %	Quarterly
2022-03-04	2022-03-11	0.20	1.63 %	Quarterly
2021-11-10	2021-12-10	0.20	1.29 %	Quarterly
2021-08-10	2021-09-10	0.20	1.77 %	Quarterly
2021-05-10	2021-06-10	0.20	1.72 %	Quarterly
2021-03-02	2021-03-10	0.20	2.51 %	Quarterly
2020-11-10	2020-12-10	0.20	3.91 %	Quarterly
2020-08-10	2020-09-10	0.20	7.27 %	Quarterly
2020-05-11	2020-06-10	0.20	6.55 %	Quarterly
2020-02-10	2020-03-10	0.20	4.98 %	Quarterly
2019-11-12	2019-12-10	0.20	4.13 %	Quarterly
2019-08-09	2019-09-10	0.20	4.49 %	Quarterly
2019-05-10	2019-06-10	0.20	3.82 %	Quarterly
2019-02-11	2019-03-11	0.20	3.26 %	Quarterly
2018-11-09	2018-12-10	0.20	3.80 %	Quarterly
2018-08-10	2018-09-10	0.20	2.64 %	Quarterly
2018-05-10	2018-06-11	0.20	2.40 %	Quarterly
2018-02-09	2018-03-09	0.20	2.58 %	Quarterly
2017-11-10	2017-12-11	0.20	2.21 %	Quarterly
2017-08-10	2017-09-11	0.20	2.65 %	Quarterly
2017-05-10	2017-06-09	0.20	2.69 %	Quarterly
2017-02-10	2017-03-10	0.20	2.74 %	Quarterly
2016-11-10	2016-12-09	0.20	3.56 %	Quarterly
2016-08-10	2016-09-09	0.20	3.82 %	Quarterly
2016-05-10	2016-06-10	0.20	3.64 %	Quarterly
2016-02-10	2016-03-10	0.20	6.19 %	Quarterly
2015-11-10	2015-12-10	0.20	3.93 %	Quarterly
2015-08-10	2015-09-10	0.20	3.55 %	Quarterly
2015-05-11	2015-06-10	0.20	2.72 %	Quarterly
2015-02-10	2015-03-10	0.20	3.05 %	Quarterly
2014-11-10	2014-12-10	0.20	3.19 %	Quarterly
2014-08-11	2014-09-10	0.20	3.08 %	Quarterly
2014-05-09	2014-06-10	0.20	2.86 %	Quarterly
2014-02-10	2014-03-10	0.20	3.16 %	Quarterly
2013-11-12	2013-12-10	0.20	3.45 %	Quarterly
2013-08-09	2013-09-10	0.20	3.34 %	Quarterly
2013-05-10	2013-06-10	0.20	3.30 %	Quarterly
2013-02-11	2013-03-11	0.20	3.42 %	Quarterly
2012-11-09	2012-12-10	0.20	3.78 %	Quarterly
2012-08-10	2012-09-10	0.20	3.86 %	Quarterly
2012-05-10	2012-06-11	0.20	3.99 %	Quarterly
2012-02-10	2012-03-09	0.20	3.58 %	Quarterly
2011-11-10	2011-12-09	0.20	4.08 %	Quarterly
2011-08-10	2011-09-09	0.20	4.52 %	Quarterly
2011-05-10	2011-06-10	0.20	3.26 %	Quarterly
2011-02-10	2011-03-10	0.20	4.21 %	Quarterly
2010-11-10	2010-12-10	0.20	4.10 %	Quarterly
2010-08-10	2010-09-10	0.20	3.97 %	Quarterly
2010-05-10	2010-06-10	0.20	4.14 %	Quarterly
2010-02-10	2010-03-10	0.20	5.19 %	Quarterly
2009-11-10	2009-12-10	0.20	5.07 %	Quarterly
2009-08-10	2009-09-10	0.20	5.72 %	Quarterly
2009-05-11	2009-06-10	0.20	6.30 %	Quarterly
2009-02-10	2009-03-10	0.20	5.48 %	Quarterly
2008-11-10	2008-12-10	0.20	4.74 %	Quarterly
2008-08-11	2008-09-10	0.20	2.83 %	Quarterly
2008-05-09	2008-06-10	0.20	3.91 %	Quarterly
2008-02-11	2008-03-10	0.20	3.98 %	Quarterly
2007-11-09	2007-12-10	0.20	3.95 %	Quarterly
2007-08-10	2007-09-10	0.20	4.13 %	Quarterly
2007-05-10	2007-06-11	0.20	4.38 %	Quarterly
2007-02-09	2007-03-09	0.20	4.87 %	Quarterly
2006-11-10	2006-12-11	0.20	4.66 %	Quarterly
2006-08-10	2006-09-11	0.20	5.26 %	Quarterly
2006-05-10	2006-06-09	0.20	4.20 %	Quarterly
2006-02-10	2006-03-10	0.20	3.88 %	Quarterly
2005-11-10	2005-12-09	0.20	4.28 %	Quarterly
2005-08-10	2005-09-09	0.20	4.50 %	Quarterly
2005-05-10	2005-06-10	0.20	4.30 %	Quarterly
2005-02-10	2005-03-10	0.20	3.30 %	Quarterly
2004-11-10	2004-12-10	0.20	3.87 %	Quarterly
2004-08-10	2004-09-10	0.20	4.92 %	Quarterly
2004-05-10	2004-06-10	0.20	4.78 %	Quarterly
2004-02-10	2004-03-10	0.20	4.49 %	Quarterly
2003-11-10	2003-12-10	0.20	4.52 %	Quarterly
2003-08-11	2003-09-10	0.20	4.90 %	Quarterly
2003-05-09	2003-06-10	0.20	4.52 %	Quarterly
2003-02-10	2003-03-10	0.20	5.03 %	Quarterly
2002-11-11	2002-12-10	0.20	5.10 %	Quarterly
2002-08-09	2002-09-10	0.20	4.48 %	Quarterly
2002-05-10	2002-06-10	0.20	4.36 %	Quarterly
2002-02-11	2002-03-11	0.20	5.37 %	Quarterly
2001-11-09	2001-12-10	0.20	5.43 %	Quarterly
2001-08-10	2001-09-10	0.20	5.00 %	Quarterly
2001-05-10	2001-06-11	0.20	4.44 %	Quarterly
2001-02-09	2001-03-09	0.20	4.29 %	Quarterly
2000-11-10	2000-12-11	0.20	4.49 %	Quarterly
2000-08-10	2000-09-11	0.20	4.79 %	Quarterly
2000-05-10	2000-06-09	0.20	4.49 %	Quarterly
2000-02-10	2000-03-10	0.20	4.74 %	Quarterly
1999-11-10	1999-12-10	0.20	5.34 %	Quarterly
1999-08-10	1999-09-10	0.20	6.15 %	Quarterly
1999-05-10	1999-06-10	0.20	5.18 %	Quarterly
1999-01-19	1999-03-10	0.30	4.46 %	Quarterly
1998-11-10	1998-12-10	0.30	3.92 %	Quarterly
1998-08-10	1998-09-10	0.30	3.57 %	Quarterly
1998-05-11	1998-06-10	0.30	2.64 %	Quarterly
1998-02-10	1998-03-10	0.30	2.60 %	Quarterly
1997-11-10	1997-12-10	0.30	2.48 %	Quarterly
1997-08-08	1997-09-10	0.30	2.76 %	Quarterly
1997-05-09	1997-06-10	0.30	2.83 %	Quarterly
1997-02-10	1997-03-10	0.30	3.30 %	Quarterly
1996-11-08	1996-12-10	0.30	2.91 %	Quarterly
1996-08-09	1996-09-10	0.60	2.80 %	Quarterly
1996-05-10	1996-06-10	0.60	2.78 %	Quarterly
1996-02-09	1996-03-08	0.60	2.85 %	Quarterly
1995-11-10	1995-12-08	0.60	3.56 %	Quarterly
1995-08-10	1995-09-08	0.60	3.92 %	Quarterly
1995-05-10	1995-06-09	0.60	4.13 %	Quarterly
1995-02-10	1995-03-10	0.60	4.49 %	Quarterly
1994-11-10	1994-12-09	0.55	4.17 %	Quarterly
1994-08-10	1994-09-09	0.55	3.88 %	Quarterly
1994-05-10	1994-06-10	0.55	4.27 %	Quarterly
1994-02-10	1994-03-10	0.55	4.52 %	Quarterly
1993-11-10	1993-12-10	0.55	4.73 %	Quarterly
1993-08-10	1993-09-10	0.55	5.17 %	Quarterly
1993-05-10	1993-06-10	0.55	4.97 %	Quarterly
1993-02-10	1993-03-10	0.55	5.29 %	Quarterly
1992-11-10	1992-12-10	0.55	5.82 %	Quarterly
1992-08-10	1992-09-10	0.55	4.94 %	Quarterly
1992-05-11	1992-06-10	0.55	4.09 %	Quarterly
1992-02-10	1992-03-10	0.55	4.61 %	Quarterly
1991-11-12	1991-12-10	0.55	4.93 %	Quarterly
1991-08-09	1991-09-10	0.55	4.37 %	Quarterly
1991-05-10	1991-06-10	0.55	4.98 %	Quarterly
1991-02-11	1991-03-08	0.55	4.97 %	Quarterly
1990-11-09	1990-12-10	0.55	6.99 %	Quarterly
1990-08-10	1990-09-10	0.55	4.92 %	Quarterly
1990-05-10	1990-06-08	0.55	3.89 %	Quarterly
1990-02-09	1990-03-09	0.50	3.32 %	Quarterly
1989-11-08	1989-12-08	0.50	3.46 %	Quarterly
1989-08-09	1989-09-08	0.50	2.93 %	Quarterly
1989-05-10	1989-06-09	0.50	3.47 %	Quarterly
1989-02-09	1989-03-10	0.45	3.39 %	Quarterly
1988-11-09	1988-12-09	0.45	3.54 %	Quarterly
1988-08-10	1988-09-09	0.45	3.52 %	Quarterly
1988-05-11	1988-06-10	0.40	3.21 %	Quarterly
1988-02-09	1988-03-09	0.40	3.79 %	Quarterly
1987-11-10	1987-12-09	0.40	4.11 %	Quarterly
1987-08-10	1987-09-09	0.40	4.62 %	Quarterly
1987-05-11	1987-06-10	0.40	6.54 %	Quarterly
1987-02-09	1987-03-09	0.40	8.28 %	Quarterly
		1.26	11.03 %	Quarterly
		1.18	10.67 %	Quarterly
		1.18	10.85 %	Quarterly
		1.18	12.47 %	Quarterly
		1.18	13.12 %	Quarterly
		1.18	10.94 %	Quarterly
		1.18	7.75 %	Quarterly
		1.18	3.37 %	Quarterly

Recent News

Olin Corporation Second Quarter 2026 Earnings Conference Call Announcement

CLAYTON, Mo., June 25, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, July 31, 2026, at 9:00 a.m.

2026-06-25 16:05:00

Huntsman Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Huntsman Corporation - HUN

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Huntsman Corporation (NYSE: HUN) to Olin Corporation (NYSE: OLN). Under the terms of the proposed transaction, shareholders of Huntsman will receive 0.5476 shares of Olin for each share of Huntsman that they own. KSF is seeking to determine whether this consideration and the process that led to it ar.

2026-06-18 16:18:00

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Olin Corporation (NYSE: OLN)

NEW YORK, June 17, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Olin Corporation (NYSE: OLN ) related to its merger with Huntsman Corporation.

2026-06-17 13:50:00

OLIN and HUNTSMAN Announce Transformative Merger of Equals to Create a $12+ Billion Integrated North American Chemicals Leader

Complementary upstream and downstream capabilities to enhance integration and enable the combined company to better create value across cycles, products and regions $400+ million of identified and actionable cost synergies and integration benefits Enhanced financial profile and cost position expected to provide greater performance through the cycle, cash flow generation and growth optionality Ken Lane to serve as Chief Executive Officer and Peter Huntsman to serve as non-executive Chairman of the Board of Directors of the combined company Joint investor call and webcast scheduled for June 16, 2026 at 8:00 a.m. Eastern Time CLAYTON, Missouri and THE WOODLANDS, Texas, June 16, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) and Huntsman Corporation (NYSE: HUN) today announced that they have entered into a definitive agreement to combine in an all-stock merger of equals to create a leading North American chemicals company.

2026-06-16 06:00:00

Olin Announces First Quarter 2026 Results

Highlights First quarter 2026 net loss of ($83.0) million, or ($0.73) per diluted share Quarterly adjusted EBITDA of $86.2 million CLAYTON, Mo., May 7, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the first quarter ended March 31, 2026.

2026-05-07 16:05:00

Olin Corporation First Quarter 2026 Earnings Conference Call Announcement

CLAYTON, Mo., April 2, 2026 /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced today that on Friday, May 8, 2026, at 9:00 a.m.

2026-04-02 16:05:00

Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to faricimab New anatomic data demonstrates OLN324 achieves faster, greater, and more durable reductions in wAMD pigment epithelial detachment (PED) thickness versus faricimab Ollin and Innovent Biologics adva ncing OLN324 into global Phase 3 studies in DME and wAMD in 2026 SAN FRANCISCO and SUZHOU, China, March 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported final, 20-week study completion data from its randomized, head-to-head Phase 1b JADE clinical study comparing OLN324(Innovent R&D code IBI324) , a higher-potency, smaller-format, higher-molar dose VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). Final results released include favorable durability data for OLN324 compared to faricimab and new anatomic data showing faster, greater, and more durable control of wAMD pigment epithelial detachments (PEDs) with OLN324.

2026-03-30 20:00:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions